Table 1.
Microorganisms tested for growth inhibition by the investigational product
| Microorganism | Comments |
|---|---|
| Gram-positive bacteria | |
| Staphylococcus aureus USA100 (clinical isolate from previous study) | MRSA, clinical isolate |
| S. aureus ATCC 33592 | MRSA |
| S. aureus BAA-44 | Multidrug resistant |
| S. epidermidis ATCC 35984 | Biofilm former |
| Enterococcus faecalis ATCC 51299 | VRE |
| E. faecium ATCC 700221 | VRE |
| Gram-negative bacteria | |
| Pseudomonas aeruginosa BAA-2108 | Multidrug resistant |
| P. aeruginosa PA-01 (from Dr. Gregory Schultz, University of Florida) | Biofilm former |
| Acinetobacter baumannii BAA-1605 | Multidrug resistant |
| Escherichia coli BAA-2469 | Multidrug resistant, NDM-1 |
| Klebsiella pneumoniae BAA-2146 | Multidrug resistant, NDM-1 |
| Enterobacter cloacae ATCC 23355 | Drug resistant |
| Serratia marcescens ATCC 14756 | Reference strain |
| Yeast | |
| Candida albicans ATCC 10231 | Reference strain |
| C. tropicalis ATCC 9968 | Reference strain |
| C. glabrata ATCC 15545 | Reference strain |
NDM-1, New Delhi metallo-beta-lactamase multidrug-resistant strain; MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant Enterococcus.